Article
Cholesteryl Ester Transfer Protein as a Drug Target for Cardiovascular Disease
2020-09-09
Abstract excerpt
Drug development of cholesteryl ester transfer protein (CETP) inhibition to prevent coronary heart disease (CHD) has yet to deliver licensed medicines. To distinguish compound from drug target failure, we compared evidence from clinical trials and Mendelian randomization (MR) results. Findings from meta-analyses of CETP inhibitor trials (≥ 24 weeks follow-up) were used to judge between-compound heterogeneity in tr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d4cde65-ca74-5bfc-94cc-fa2694dde4fc
- DOI
- 10.1101/2020.09.07.20189571
